Beta Bionics, Inc. (BBNX:NASDAQ) closed at $19.16 on October 23, 2026, down 0.93% on the day. The stock trades 41.4% below its 52-week high of $32.71 and 117.7% above its 52-week low of $8.80. Over the past year, it lost 8.5%. Beta Bionics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, BBNX closed higher on 115 days (46%). Its best day was April 13, 2026 (+19.98%) and its worst was January 9, 2026 (-37.04%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 1 time.
Beta Bionic is a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our product, the iLet Bionic Pancreas (iLet), is the first insulin delivery device cleared by the U.S. Food and Drug Administration to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake.
Find more stocks like BBNX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.